Green Planet Bio Engineering Co. Ltd. (GPLB) — SEC Filings
Green Planet Bio Engineering Co. Ltd. (GPLB) — 8 SEC filings. Latest: 10-Q (Nov 14, 2025). Includes 6 10-Q, 2 10-K.
View Green Planet Bio Engineering Co. Ltd. on SEC EDGAR
Overview
Green Planet Bio Engineering Co. Ltd. (GPLB) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 14, 2025: Green Planet Bio Engineering Co. Ltd. (GPLB) reported a net loss of $8,599 for the three months ended September 30, 2025, an increase from a net loss of $5,425 for the same period in 2024. For the nine months ended September 30, 2025, the net loss was $19,544, an improvement from a net loss of $22,7
Sentiment Summary
Across 8 filings, the sentiment breakdown is: 2 bearish, 6 neutral. The dominant filing sentiment for Green Planet Bio Engineering Co. Ltd. is neutral.
Filing Type Overview
Green Planet Bio Engineering Co. Ltd. (GPLB) has filed 6 10-Q, 2 10-K with the SEC between Mar 2024 to Nov 2025.
Filings by Year
Recent SEC Filings (8)
| Date | Form | Description | Risk |
|---|---|---|---|
| Nov 14, 2025 | 10-Q | GPLB's Shell Status Persists Amidst Mounting Deficit | high |
| Aug 8, 2025 | 10-Q | GPLB Reports No Revenue, Significant Post-Period Dilution | high |
| May 15, 2025 | 10-Q | Green Planet Bio Engineering Files Q1 2025 10-Q | low |
| Mar 7, 2025 | 10-K | Green Planet Bio Engineering Files 2024 10-K | low |
| Nov 14, 2024 | 10-Q | Green Planet Bio Engineering Files Q3 2024 10-Q | low |
| Aug 14, 2024 | 10-Q | Green Planet Bio Engineering Files Q2 2024 10-Q | low |
| May 9, 2024 | 10-Q | Green Planet Bio Engineering Co., Ltd. Files Quarterly Report (10-Q) for Period Ended March 31, 2024 | low |
| Mar 29, 2024 | 10-K | Green Planet Bio Engineering Co., Ltd. Files 2023 Annual Report on Form 10-K | low |
Risk Profile
Risk Assessment: Of GPLB's 8 recent filings, 2 were flagged as high-risk, 0 as medium-risk, and 6 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $0 |
| Net Income | -$8,599 |
| EPS | ($*) |
| Debt-to-Equity | N/A |
| Cash Position | $0 |
| Operating Margin | N/A |
| Total Assets | $0 |
| Total Debt | $484,678 |
Key Executives
- Aventura, Florida
Industry Context
Green Planet Bio Engineering Co. Ltd. operates in the biotechnology sector, which is characterized by high research and development costs, long product development cycles, and significant regulatory hurdles. As a shell corporation with no active operations, GPLB is not currently participating in this competitive landscape. Its future success hinges entirely on its ability to identify and execute a merger or acquisition with an existing business in this or another sector.
Top Tags
10-Q (5) · bio-engineering (3) · SEC Filing (2) · financials (2) · 10-K (2) · Green Planet Bio Engineering (2) · Shell Company (1) · Going Concern Risk (1) · Related Party Transactions (1) · Net Loss (1)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net loss for nine months ended Sep 30, 2025 | $19,544 | Decreased from $22,753 in the prior year, but still a loss. |
| Net loss for three months ended Sep 30, 2025 | $8,599 | Increased from $5,425 in the prior year, indicating worsening short-term performance. |
| Working capital deficit as of Sep 30, 2025 | $484,678 | Increased from $465,134 as of Dec 31, 2024, highlighting deteriorating liquidity. |
| Accumulated deficit as of Sep 30, 2025 | $1,114,298 | Increased from $1,094,754 as of Dec 31, 2024, showing continued losses. |
| Amount due to a related party as of Sep 30, 2025 | $479,148 | Increased from $459,634 as of Dec 31, 2024, indicating growing reliance on external funding. |
| Common shares outstanding as of Nov 14, 2025 | 20,006,402 | Consistent, but with no underlying business value. |
| Cash balance as of Sep 30, 2025 | $0 | No cash on hand, underscoring complete reliance on related party. |
| Revenue | $0.00 | No revenue reported for the quarter ended June 30, 2025 |
| Net Income | $0.00 | No net income reported for the quarter ended June 30, 2025 |
| Common Shares Outstanding | 20,006,402 | As of June 30, 2025, unchanged from December 31, 2024 |
| Series A Preferred Stock Shares | 10,000,000 | Outstanding as of June 30, 2025 |
| Common Shares Issued | 250,000,000 | Subsequent event on June 29, 2025, indicating significant dilution |
| Retained Earnings | 20006402 | As of March 31, 2025 |
| Additional Paid-In Capital | 20006402 | As of March 31, 2025 |
| Common Stock | 20006402 | As of March 31, 2025 |
Frequently Asked Questions
What are the latest SEC filings for Green Planet Bio Engineering Co. Ltd. (GPLB)?
Green Planet Bio Engineering Co. Ltd. has 8 recent SEC filings from Mar 2024 to Nov 2025, including 6 10-Q, 2 10-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of GPLB filings?
Across 8 filings, the sentiment breakdown is: 2 bearish, 6 neutral. The dominant sentiment is neutral.
Where can I find Green Planet Bio Engineering Co. Ltd. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Green Planet Bio Engineering Co. Ltd. (GPLB) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Green Planet Bio Engineering Co. Ltd.?
Key financial highlights from Green Planet Bio Engineering Co. Ltd.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for GPLB?
The investment thesis for GPLB includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Green Planet Bio Engineering Co. Ltd.?
Key executives identified across Green Planet Bio Engineering Co. Ltd.'s filings include Aventura, Florida.
What are the main risk factors for Green Planet Bio Engineering Co. Ltd. stock?
Of GPLB's 8 assessed filings, 2 were flagged high-risk, 0 medium-risk, and 6 low-risk.
What are recent predictions and forward guidance from Green Planet Bio Engineering Co. Ltd.?
Forward guidance and predictions for Green Planet Bio Engineering Co. Ltd. are extracted from SEC filings as they are enriched.